Referencing for people who value simplicity, privacy, and speed.Get Citationsy
← Back to Search
Age-associated Prevalence And Risk Factors Of Lewy Body Pathology In A General Population: The Hisayama Study
Y. Wakisaka, A. Furuta, Y. Tanizaki, Y. Kiyohara, M. Iida, T. Iwaki
Published 2003 · Medicine
Save to my Library
Download PDFAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
In dementia with Lewy bodies (DLB), the Lewy bodies (LBs) are an essential substrate. Although LB pathology has gained increasing attention as one of the major causes of dementia, little is known about the exact prevalence of LB pathology in the general population. In addition, the pathology of Alzheimer-type dementia (ATD) is frequently associated with DLB. To investigate the prevalence of LB pathology in a community-based population and to evaluate the relationship between LB and ATD pathology, we performed an analysis of 102 consecutive autopsy cases. The survey extended over 2.5 years and autopsy rate was 70.5%. LB pathology was detected using α-synuclein immunohistochemistry and was assessed based on consensus guidelines for DLB. ATD pathology was evaluated by both CERAD and NIA-RI criteria. Twenty-nine subjects were clinically demented. LB pathology was present in 23 (22.5%) of 102 cases, and in 12 (41.4%) of the demented subjects. The LB score was not significantly different between DLB cases and non-demented subjects with LB pathology (nd-LB), while the Braak stages were significantly different between the two groups. Prevalence of LB pathology constantly increased with age. DLB cases accompanying severe ATD pathology showed more rapid increase of LB scores than did DLB cases without severe ATD pathology. Moreover, DLB cases with severe ATD pathology had poorer prognoses than those without severe ATD pathology. Our results suggested that aging and severe ATD pathology have a strong effect on the evolution of LB pathology.
This paper references
Neuropathological stageing of Alzheimer-related changes
H. Braak (2004)
Numerous and widespread α-synuclein-negative Lewy bodies in an asymptomatic patient
S. V. van Duinen (1999)
Consensus recommendations for the postmortem diagnosis of Alzheimer's disease
M. Ball (1997)
Lewy Bodies in Alzheimer's Disease: A Neuropathological Review of 145 Cases Using α‐Synuclein Immunohistochemistry
R. Hamilton (2000)
Regional Distribution of α‐Synuclein Pathology in Unimpaired Aging and Alzheimer Disease
L. Parkkinen (2003)
Neuropathological stageing of Alzheimer related changes correlates with psychometrically assessed intellectual status: H. Braak, C. Duyckaerts, E. Braak and F. Piette. Depts of Anatomy and Neuropathology, Goethe University and Hopital de la Salpetriere, Frankfurt, Germany and Paris, France
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
S. S. Mirra (1991)
Where Does Parkinson Disease Pathology Begin in the Brain?
K. Del Tredici (2002)
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop.
I. McKeith (1996)
Lewy body prevalence in the aging brain: relationship to neuropsychiatric disorders, Alzheimer-type pathology and catecholaminergic nuclei
R. Perry (1990)
Research evaluation and prospective diagnosis of dementia with Lewy bodies.
O. Lopez (2002)
α-Synuclein in Lewy bodies
M. Spillantini (1997)
The frequency of Lewy bodies in a consecutive autopsy series.
K. Jellinger (1999)
Incidence and Risk Factors for Subtypes of Cerebral Infarction in a General Population: The Hisayama Study
Y. Tanizaki (2000)
Clinicopathological studies on diffuse Lewy body disease
K. Kosaka (2000)
The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
W. Gibb (1988)
The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease.
S. E. Arnold (1991)
Epidemiological and clinicopathological study on cerebrovascular disease in Japan.
S. Katsuki (1966)
Clinical diagnosis of Alzheimer's disease
G. Mckhann (1984)
Contribution of Lewy body inclusions to dementia in patients with and without Alzheimer disease neuropathological conditions.
V. Haroutunian (2000)
The frequency of Lewy bodies in a consecutive autopsy series.
Lindboe Cf (1998)
G. Román (1993)
Report of the second dementia with Lewy body international workshop
I. McKeith (1999)
Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales
M. Esiri (2001)
α-Synuclein is expressed in a variety of brain tumors showing neuronal differentiation
M. Kawashima (2000)
Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease
K. Jellinger (2002)
A clinicopathologic study of 100 cases of Parkinson's disease.
A. Hughes (1993)
The topographical distribution of neurofibrillary tangles and neuritic plaque in the cerebral cortex of patients with Alzheimer ’ s disease
H Baba (1991)
Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.
M. Baba (1998)
Plaque‐Only Alzheimer Disease is Usually the Lewy Body Variant, and Vice Versa
L. Hansen (1993)
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)
I. McKeith (1996)
Comparison of Lewy body variant of Alzheimer’s disease with pure Alzheimer’s disease
A. Heyman (1999)
Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population
T. Yoshitake (1995)
Clinical and quantitative pathologic correlates of dementia with Lewy bodies
E. Gómez-Tortosa (1999)
Alzheimer neuropathologic alterations in aged cognitively normal subjects.
D. Davis (1999)
Neuropathological diagnoses in elderly patients in Oslo: Alzheimer's disease, Lewy body disease, vascular lesions.
P. Ince (1995)
Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes.
C. F. Lippa (1998)
Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease
B. Hyman (1997)
Cognitive decline is faster in Lewy body variant than in Alzheimer's disease
J. Olichney (1998)
α‐Synuclein Inclusions in Amygdala in the Brains of Patients with the Parkinsonism‐Dementia Complex of Guam
M. Yamazaki (2000)
Patho - logical correlates of late - onset dementia in a multicentre , communitybased population in England and Wales
JM Olichney (2001)
Changing patterns in the prevalence of dementia in a Japanese community: the Hisayama study.
Y. Kiyohara (1994)
Dementia with Lewy Bodies. A Distinct Non‐Alzheimer Dementia Syndrome?
P. Ince (1998)
Purification and characterization of Lewy bodies from the brains of patients with diffuse Lewy body disease.
T. Iwatsubo (1996)
Regional distribution of alpha-synuclein pathology in unimpaired aging and Alzheimer disease.
L. Parkkinen (2003)
Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra
Juha O. Rinne (1989)
α‐Synuclein pathology is highly dependent on the case selection
L. Parkkinen (2001)
This paper is referenced by
A critical evaluation of the Braak staging scheme for Parkinson's disease
R. Burke (2008)
Pathological Influences on Clinical Heterogeneity in Lewy Body Diseases
David G Coughlin (2019)
α‐synuclein RT‐QuIC in cerebrospinal fluid of LRRK2‐linked Parkinson's disease
A. Garrido (2019)
Patterns and stages of &agr;-synucleinopathy: Relevance in a population-based cohort
J. Zaccai (2008)
Clinicopathological Outline of Dementia with Lewy Bodies Applying the Revised Criteria: The Hisayama Study
Kouhei Fujimi (2008)
Multiple brain pathologies in dementia are common
M. Woodward (2010)
Dementia in the oldest old
Z. Yang (2013)
Chapter 33 Alpha-Synucleinopathy and Neuropsychological Symptoms in a Population-Based Cohort of the Elderly
Julia Zaccai (2013)
α-Synuclein enhances secretion and toxicity of amyloid beta peptides in PC12 cells
A. Kaźmierczak (2008)
A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders.
K. Jellinger (2009)
What best differentiates Lewy body from Alzheimer's disease in early-stage dementia?
P. Tiraboschi (2006)
Critical appraisal of brain pathology staging related to presymptomatic and symptomatic cases of sporadic Parkinson's disease.
G. Halliday (2006)
Delta-secretase cleavage of Tau mediates its pathology and propagation in Alzheimer's disease.
Seong Su Kang (2020)
Patterns and stages of α-synucleinopathy
Julia Zaccai (2008)
Temporal course of neurodegenerative effects on cognition in old age.
R. Wilson (2016)
Sex differences for phenotype in pathologically defined dementia with Lewy bodies
Ece Bayram (2021)
Association of Longitudinal β-Amyloid Accumulation Determined by Positron Emission Tomography With Clinical and Cognitive Decline in Adults With Probable Lewy Body Dementia
Z. Nedelska (2019)
Neuropathological diagnoses and clinical correlates in older adults in Brazil: A cross-sectional study
C. Suemoto (2017)
Argyrophilic grain disease as a neurodegenerative substrate in late-onset schizophrenia and delusional disorders
S. Nagao (2013)
Progressive changes in regulation of apolipoproteins E and J in glial cultures during postnatal development and aging
N. Patel (2004)
The Role of 123I-Metaiodobenzylguanidine Myocardial Scintigraphy in the Diagnosis of Lewy Body Disease in Patients with Dementia in a Memory Clinic
H. Hanyu (2006)
Age and apoE associations with complex pathologic features in Alzheimer's disease
G. Jicha (2008)
Population-based neuropathological studies of dementia: design, methods and areas of investigation – a systematic review
J. Zaccai (2006)
Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts
K. Jellinger (2012)
Impact of α-Synuclein Pathology on Aging
L. Parkkinen (2005)
Neuropathobiology of non-motor symptoms in Parkinson disease
K. Jellinger (2015)
Pathophysiology of synuclein aggregation in Lewy body disease
E. Mukaetova-Ladinska (2006)
Predicting Survival in Dementia With Lewy Bodies With Hippocampal Volumetry
Jonathan Graff-Radford (2016)
Where and how alpha‐synuclein pathology spreads in Parkinson’s disease:
K. Wakabayashi (2020)
Prevalence of mixed pathologies in the aging brain
Jasmin Rahimi (2014)
Chapter 28 Alpha-Synucleinopathy and Neuropsychological Symptoms in a Population-Based Cohort of the Elderly
J. Zaccai (2012)
Neuropathology of Parkinson’s Disease
K. Jellinger (2014)See more